Copertina

Epidermolysis Bullosa Acquisita due to Epitope Spreading in a Patient With Recurrent Bullous Pemphigoid

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Athina‐Ioanna Daponte, Anastasia Tsitlakidou, Athanasia Tsaousi, Parthena Meltzanidou, Aikaterini Kyriakou, Anastasia Giannakou, Elizabeth Lazaridou, Aikaterini Patsatsi
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	International Journal of Dermatology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Association of Serum Levels of Total‐IgE and Specific antiBP180 IgE Autoantibodies With Disease Activity and Severity in Patients With Bullous Pemphigoid
di: Aikaterini Kyriakou, et al.
Pubblicazione: (2025)

Bullous pemphigoid: Investigating the risk of losing functional autonomy in everyday life
di: Aikaterini Patsatsi, et al.
Pubblicazione: (2025)

Epidermolysis Bullosa Acquisita With Extensive Esophageal Erosions
di: Erina Taniguchi, et al.
Pubblicazione: (2025)

Lewis blood group antigens and ABH secretor status in patients with pemphigus
di: Foteini Lamprou, et al.
Pubblicazione: (2024)

Epidermolysis Bullosa and Psychodermatology
di: Csanád Szabó
Pubblicazione: (2025)

Multidisciplinary Management of Epidermolysis Bullosa
di: James A. Feinstein, et al.
Pubblicazione: (2026)

Epidermolysis Bullosa: Fragile Skin, Fragile Hope
di: Pragya Kafley
Pubblicazione: (2025)

Dapagliflozin‐Associated Bullous Pemphigoid
di: Xun Feng, et al.
Pubblicazione: (2025)

Involvement of Ferroptosis in Bullous Pemphigoid Pathogenesis
di: Shiling Geng, et al.
Pubblicazione: (2025)

Bibliometric Analysis of the 50 Most Cited Publications in Epidermolysis Bullosa
di: Evelyn F. Fagan, et al.
Pubblicazione: (2025)

Immune Checkpoint Inhibitor–Associated Autoimmune Bullous Diseases: Beyond Bullous Pemphigoid
di: Ioannis‐Alexios Koumprentziotis, et al.
Pubblicazione: (2026)

Lichenoid Drug Eruption due to Telmisartan–Hydrochlorothiazide Combination Progressing to Bullous Pemphigoid: A Case Report
di: Satoko Minakawa, et al.
Pubblicazione: (2025)

Reassessing Ferroptosis in Bullous Pemphigoid: Methodological and Translational Considerations
di: Yang Li
Pubblicazione: (2025)

Novel Clinical Observations Indicative of Epidermolysis Bullosa Simplex Associated With KLHL24
di: Madison Anzelc, et al.
Pubblicazione: (2025)

Treatment Landscape for Epidermolysis Bullosa Simplex: A Review of Established and Emerging Therapies
di: Grace B. Hanrahan, et al.
Pubblicazione: (2026)

Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa—Impact of Oleogel‐ S10
di: Anna L. Bruckner, et al.
Pubblicazione: (2025)

Use of Lebrikizumab in Treatment‐Refractory Bullous Pemphigoid: Two Reports
di: Christoph Zeyen, et al.
Pubblicazione: (2026)

El Disfrute de la Experiencia Audiovisual por Personas Sordas y con Diversidad Auditiva: La Representación Visual de los Efectos Sonoros
di: Aikaterini Tsaousi
Pubblicazione: (2018)

Management of Bullous Pemphigoid in Special Populations: A Narrative Review of the Literature
di: Giulia Gasparini, et al.
Pubblicazione: (2025)

Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity
di: Yutong Ran, et al.
Pubblicazione: (2025)

Dual Immune‐Related Toxicities: Secukinumab‐Induced Bullous Pemphigoid Following ICI ‐Associated Psoriasis in a Cancer Patient
di: Ioanna A. Paschou, et al.
Pubblicazione: (2025)

Assessment of Growth Hormone and Insulin‐Like Growth Factor 1 in Children With Epidermolysis Bullosa Dystrophica
di: Mohammad El Darouti, et al.
Pubblicazione: (2025)

Long‐Term Efficacy and Safety of Oleogel‐ S10 (Birch Triterpenes) for Pediatric Patients With Epidermolysis Bullosa
di: Eli Sprecher, et al.
Pubblicazione: (2026)

A Case of Bullous Pemphigoid in a Patient With Systemic Sarcoidosis and Relapsing Polychondritis
di: Takehiro Nakamura, et al.
Pubblicazione: (2025)

Immune Checkpoint Inhibitor‐Related Bullous Pemphigoid: Distinct Clinical and Immunological Profiles
di: Min Zou, et al.
Pubblicazione: (2026)

Pediatric Bullous Pemphigoid Treated With Dupilumab: A Case Report With Good Response
di: Aldana Belén Almassio, et al.
Pubblicazione: (2025)

Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study
di: Gianluca Avallone, et al.
Pubblicazione: (2025)

A Case of Bullous Pemphigoid Coexisted With Psoriasis Vulgaris Successfully Treated by Apremilast
di: Haruna Kumagai, et al.
Pubblicazione: (2026)

BP230 ‐Type Bullous Pemphigoid is a Rare Subset of Bullous Pemphigoid Associated With a Favorable Prognosis: A Retrospective Analysis From a Tertiary Referral Center
di: Roberto Maglie, et al.
Pubblicazione: (2025)

The Clinical Efficacy and Safety of Dupilumab Monotherapy in Dystrophic Epidermolysis Bullosa: A Retrospective Real‐World Study
di: Jian-Bo Wang, et al.
Pubblicazione: (2026)

Tissue Eosinophil Counts: A Promising Marker for Optimizing Omalizumab Treatment in Bullous Pemphigoid
di: Gülfem Akin, et al.
Pubblicazione: (2025)

Real‐World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens
di: Kateryna Karpoff, et al.
Pubblicazione: (2026)

Successful Use of Upadacitinib in Treating a Child With Epidermolysis Bullosa Pruriginosa: A Case Report and Literature Review
di: Xumei Wu, et al.
Pubblicazione: (2025)

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real‐world data from a multicentre study
di: Vasiliki Nikolaou, et al.
Pubblicazione: (2024)

Junctional Epidermolysis Bullosa With Pyloric Atresia Complicated by Esophageal Atresia and Nephrotic Syndrome: A Case Report and Review of the Literature
di: Kennedy Sabharwal, et al.
Pubblicazione: (2025)

An Acid‐Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds
di: Xiaolong A. Zhou, et al.
Pubblicazione: (2025)

Revisiting the Pathology of Bullous Pemphigoid: Basal Cell Necrosis as a Diagnostic Clue and Its Pathogenic Role
di: Hsuan Chen, et al.
Pubblicazione: (2025)

The Secretome of Bullous Pemphigoid IgG ‐Treated Keratinocytes Induces a Pro‐Inflammatory Eosinophil Response
di: Adrian P. Mansini, et al.
Pubblicazione: (2026)

Differential Tumour Necrosis Factor‐Like Weak Inducer of Apoptosis ( TWEAK ) Associations in Pemphigus and Bullous Pemphigoid
di: Shiran Kang, et al.
Pubblicazione: (2026)

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development
di: Belen de Nicolas‐Ruanes, et al.
Pubblicazione: (2025)